top of page
  • Jonathan Poyer

Overview of Biotech Capital Markets Through Week Ended March 24th, 2023



Let's take a look at some highlights from the Biotech and MedTech/Diagnostics Private and Public Capital Markets and SPAC Activity Through the Week Ended March 24th, 2023.


  • Biotech: 3 Transactions (2 Follow-Ons and 1 Registered Direct) totaling just over $700 Million

  • Med Tech: No Current Week Transactions


2023 YTD


  • 37 Biotech transaction totaling just over $4.4 Billion v. 2022: 21 Biotech transactions totaling just over $3.2 Billion

  • 6 Med Tech transactions totaling just over $400 Million v. 2022: 3 Med Tech transaction just over $200 Million


Private Transactions


  • Biotech: 53 US Transactions / 19 European Transaction

  • Med Tech: 34 US Transactions / 13 European Transaction


3 views0 comments
bottom of page